Evidence map›Paper›PMID 34956962›Full record

ArticleMedical journal of the Islamic Republic of Iran2021

Epidemiological characteristics of patients with COVID-19 in Southwest of Iran from February 19 to June 20, 2020.

Habibollah Azarbakhsh, Kimia Jokari, Leila Moftakhar, Mousa Ghelichi Ghojogh, Azimeh Karimyan, Shokrollah Salmanzadeh, Mehrdad Parian Zeitooni, Rozhan Khezri, Aliasghar Valipour

Abstract read
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Habibollah AzarbakhshStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Kimia JokariStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Leila MoftakharStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Mousa Ghelichi GhojoghHealth Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Azimeh KarimyanDepartment of Health Promotion and Education, School of Public Health, Tehran University of Medical Sciences, Tehran,Iran.
Shokrollah SalmanzadehInfectious and Tropical Diseases Research Center, Health Research Institute, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mehrdad Parian ZeitooniDepartment of Disease Prevention and Control of the Deputy Minister of Health, Abadan Faculty of Medical Sciences, Abadan, Iran.
Rozhan KhezriUrmia Health Center, Urmia University of Medical Sciences, Urmia, Iran.
Aliasghar ValipourDepartment of Public Health, Abadan Faculty of Medical Sciences, Abadan, Iran.ORCID https://orcid.org/0000-0002-4976-455X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCOVID-19EepidemiologyIran

Identifiers

PMID34956962
PMCPMC8683833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.